skip to Main Content

Dr. Hidalgo Medina on MSI and Germline Testing in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Manuel Hidalgo Medina, MD, PhD, chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses microsatellite instability (MSI) and germline testing patients with pancreatic cancer.

Read more . . . 


Back To Top